Biomanufacturing revolutionizes the way we produce essential products, harnessing the power of biological systems to create a wide array of goods. At its core, biomanufacturing utilizes living organisms, such as bacteria, yeast, or mammalian cells, to produce pharmaceuticals, chemicals, food ingredients, and more. This innovative approach offers numerous advantages, including increased efficiency, sustainability, and flexibility in product design. In biopharmaceuticals, biomanufacturing plays a pivotal role in producing complex therapeutics like insulin, vaccines, and monoclonal antibodies. By leveraging genetically engineered microorganisms or cell cultures, manufacturers can produce large quantities of these lifesaving drugs with precision and consistency. Beyond pharmaceuticals, biomanufacturing extends its reach to sectors like agriculture and food production.
Engineered microorganisms can be employed to produce enzymes for food processing, bio-based chemicals for agricultural applications, and even alternative proteins to meet the growing demand for sustainable protein sources. One of the key benefits of biomanufacturing is its environmental sustainability. Unlike traditional manufacturing processes that rely heavily on fossil fuels and generate harmful byproducts, biomanufacturing often utilizes renewable resources and produces minimal waste, contributing to a greener, more sustainable future. Moreover, biomanufacturing offers unparalleled flexibility in product design. Through genetic engineering and synthetic biology techniques, researchers can tailor microorganisms to produce specific compounds or proteins with desired properties, opening doors to endless possibilities in product innovation.
Title : Distant binuclear vanadium V(II) cationic sites in zeolites and their reactivity
Jiri Dedecek, J Heyrovsky Institute of Physical Chemistry , Czech Republic
Title : Advanced nanostructures for carbon neutrality and sustainable H₂ energy
Tokeer Ahmad, Jamia Millia Islamia, India
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model via bi-odesign, bio- and chemical engineering, translational applications, and upgraded business modeling to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as a generation of unique biomarkers, biocatalysts, potential targets and translational tools towards nanodesign-driven biochemical engineering and precision medical practice
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Dimethyl ether synthesis from syngas over Cu-Zn/Al2O3 catalysts prepared using the Sol-Gel method
Uday Som, Research and Development Engineer, Japan
Title : Oxidation of methane to methanol over pairs of transition metal ions stabilized in the zeolite matrices
Jiri Dedecek, J Heyrovsky Institute of Physical Chemistry , Czech Republic
Title : The Concept and Implications of Low Carbon Green Growth
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Memory characteristics and diffusionless phase transformations in shape memory alloys
Osman Adiguzel, Firat University, Turkey
Title : The Fe PNP 15 H2O catalyst reduction catalytic test and its valorisation as acid catalyst to the methylal synthesis
Rabeharitsara Andry Tahina, GPCI-ESPA Antananarivo University, Madagascar